Laser treatment for hidradenitis suppurativa
Part of Infections, Skin clinical trials.
This study compares two types of laser treatments (Nd:YAG and Alexandrite) to see which one works better for hidradenitis suppurativa, a condition that causes painful bumps under the skin. If you join, you'll receive one of these laser treatments to help reduce your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of hidradenitis suppurativa, also called HS, at any stage
- You are between 12 and 75 years old
- You are not currently taking or have not taken in the last 2 weeks any medications for HS, like antibiotics or biologics
- You can tolerate laser therapy and wear protective eyewear
- You are not pregnant
- You are willing and able to give your consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a 1726-nm laser to reduce inflamed nodules in people with mild to moderate hidradenitis suppurativa (HS). It compares treated and untreated areas to see if the laser helps without affecting the rest of the body.
This study tests a new medicine given by injection (anti-IL-17A/F antibody) combined with a laser treatment (non-ablative dot laser) for people with mild to moderate hidradenitis suppurativa (also called HS). The goal is to see if the combination is safe and works better than current options, and might help reduce pain and flare-ups.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This trial tests if low-dose radiation therapy can help people with moderate to severe hidradenitis suppurativa (HS) that hasn't gotten better with other treatments. It's for those with sores in both armpits.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This study looks at certain immune cells (called MAIT cells) in the skin of people with hidradenitis suppurativa, a painful skin condition. It will compare samples from people before they start a new biologic treatment, and may help doctors understand how these treatments work.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.